Matthew Kashima

Medicine & Life Sciences

1. In Situ Hybridization 100%
2. Otolaryngology 92%
3. Cerebellar Neoplasms 85%
4. SARS Virus 80%
5. Latex Hypersensitivity 80%
6. Specimen Handling 74%
7. Turbinates 69%
8. Papillomaviridae 67%
9. Otolaryngologists 67%
10. Latex 63%
11. Dilatation 45%
12. Nose 44%
13. Pathologic Constriction 43%
14. Neck 41%
15. Radiation 41%
16. Head 40%
17. Adenosquamous Carcinoma 38%
18. Polymerase Chain Reaction 36%
19. Carcinoma 36%
20. Esophageal Stenosis 35%
21. Hypopharynx 35%
22. Pathology 34%
23. Neoplasm Metastasis 33%
24. Nasopharynx 32%
25. Bronchi 29%
26. Larynx 28%
27. Centers for Disease Control and Prevention (U.S.) 28%
28. Gold 27%
29. Geriatrics 26%
30. Esophagus 25%
31. Uterine Cervical Neoplasms 25%
32. DNA Probes 24%
33. Human papillomavirus 16 24%
34. Squamous Cell Carcinoma 22%
35. Biotin 22%
36. Primary Health Care 21%
37. Population 21%
38. DNA 19%
39. Radiotherapy 18%
40. Exanthema 18%
41. Human papillomavirus 18 17%
42. Laryngostenosis 14%
43. Recurrent respiratory papillomatosis 14%
44. HeLa Cells 13%
45. Formaldehyde 12%
46. Paraffin 12%
47. Brain Stem 12%
48. Bronchial Spasm 11%
49. Ventriculoperitoneal Shunt 11%